Sea Mild Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	348.45	318.82	257.02	202.65	163.82	207.88
Revenue Growth (YoY)	29.29%	24.05%	26.83%	23.71%	-21.20%	-2.92%
Cost of Revenue	255.35	227.54	200.65	166.49	144.73	180.6
Gross Profit	93.09	91.28	56.37	36.16	19.09	27.28
Selling, General & Admin	68.54	64.49	48.15	45.21	47.72	61.13
Research & Development	5.45	4.52	3.38	2.97	4.9	5
Operating Expenses	73.99	69	51.54	48.14	51.08	63.86
Operating Income	19.1	22.28	4.83	-11.98	-31.99	-36.57
Interest Expense	-1.72	-1.26	-0.97	-0.68	-0.83	-1.12
Interest & Investment Income	0.58	0.44	0.3	0.08	0.11	0.04
Currency Exchange Gain (Loss)	-0.04	0.18	-0.07	0.13	-0.13	-0.03
Other Non Operating Income (Expenses)	4.46	3.34	0.95	0.07	-2.45	-2.69
EBT Excluding Unusual Items	22.38	24.97	5.04	-12.38	-35.3	-40.37
Gain (Loss) on Sale of Assets	-	-	0.28	-0.11	3.3	-2.39
Asset Writedown	-	7.97	-	-9	-10	-7
Other Unusual Items	-	-	0.81	0.01	-	2.51
Pretax Income	22.38	32.94	6.13	-21.48	-42	-47.25
Income Tax Expense	0.95	0.95	-0.06	-0.1	10.06	8.25
Earnings From Continuing Operations	21.43	31.99	6.19	-21.38	-52.05	-55.5
Net Income	21.43	31.99	6.19	-21.38	-52.05	-55.5
Net Income to Common	21.43	31.99	6.19	-21.38	-52.05	-55.5
Net Income Growth	10.00%	417.02%	-	-	-	-
Shares Outstanding (Basic)	19	19	19	19	19	19
Shares Outstanding (Diluted)	19	19	19	19	19	19
Shares Change (YoY)	-	-	-	-	-	1.16%
EPS (Basic)	1.11	1.66	0.32	-1.11	-2.70	-2.87
EPS (Diluted)	1.11	1.66	0.32	-1.11	-2.70	-2.87
EPS Growth	10.00%	417.70%	-	-	-	-
Free Cash Flow	10.46	22.82	7.59	11.71	-15.2	-5.96
Free Cash Flow Per Share	0.54	1.18	0.39	0.61	-0.79	-0.31
Gross Margin	26.72%	28.63%	21.93%	17.84%	11.65%	13.12%
Operating Margin	5.48%	6.99%	1.88%	-5.91%	-19.53%	-17.59%
Profit Margin	6.15%	10.03%	2.41%	-10.55%	-31.77%	-26.70%
Free Cash Flow Margin	3.00%	7.16%	2.95%	5.78%	-9.28%	-2.86%
EBITDA	29.15	28.12	7.38	-7.74	-21.99	-27.96
EBITDA Margin	8.37%	8.82%	2.87%	-3.82%	-13.42%	-13.45%
D&A For EBITDA	10.05	5.84	2.55	4.24	10	8.61
EBIT	19.1	22.28	4.83	-11.98	-31.99	-36.57
EBIT Margin	5.48%	6.99%	1.88%	-5.91%	-19.53%	-17.59%
Effective Tax Rate	4.23%	2.88%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.